Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1991 1
1994 1
1995 3
1996 2
1997 2
2000 2
2001 2
2002 2
2003 1
2004 1
2005 1
2006 2
2007 2
2008 2
2009 1
2010 3
2011 3
2012 5
2013 2
2014 5
2015 9
2016 7
2017 4
2018 4
2019 4
2020 6
2021 15
2022 10
2023 6
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. Among authors: mar n. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
O'Donnell PH, Milowsky MI, Petrylak DP, Hoimes CJ, Flaig TW, Mar N, Moon HH, Friedlander TW, McKay RR, Bilen MA, Srinivas S, Burgess EF, Ramamurthy C, George S, Geynisman DM, Bracarda S, Borchiellini D, Geoffrois L, Maroto Rey JP, Ferrario C, Carret AS, Yu Y, Guseva M, Homet Moreno B, Rosenberg JE. O'Donnell PH, et al. Among authors: mar n. J Clin Oncol. 2023 Sep 1;41(25):4107-4117. doi: 10.1200/JCO.22.02887. Epub 2023 Jun 27. J Clin Oncol. 2023. PMID: 37369081 Free PMC article. Clinical Trial.
Drug extravasation with Enfortumab vedotin.
Grant CR, de Kouchkovsky D, Kalebasty AR, Mar N. Grant CR, et al. Among authors: mar n. J Oncol Pharm Pract. 2023 Oct;29(7):1789-1792. doi: 10.1177/10781552231185505. Epub 2023 Jul 4. J Oncol Pharm Pract. 2023. PMID: 37401244 Free PMC article.
Neural control of choroidal blood flow.
Reiner A, Fitzgerald MEC, Del Mar N, Li C. Reiner A, et al. Among authors: del mar n. Prog Retin Eye Res. 2018 May;64:96-130. doi: 10.1016/j.preteyeres.2017.12.001. Epub 2017 Dec 8. Prog Retin Eye Res. 2018. PMID: 29229444 Free PMC article. Review.
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Milowsky MI, O'Donnell PH, Hoimes CJ, Petrylak DP, Flaig TW, Moon HH, Friedlander TW, Mar N, McKay RR, Srinivas S, Gravis G, Ramamurthy C, Bupathi M, Bracarda S, Wright P, Hepp Z, Carret AS, Yu Y, Dillon R, Kataria R, Beaumont JL, Purnajo I, Rosenberg JE. Milowsky MI, et al. Among authors: mar n. J Clin Oncol. 2024 Apr 20;42(12):1403-1414. doi: 10.1200/JCO.23.01547. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215355 Free PMC article. Clinical Trial.
Pathway tracing using biotinylated dextran amines.
Reiner A, Veenman CL, Medina L, Jiao Y, Del Mar N, Honig MG. Reiner A, et al. Among authors: del mar n. J Neurosci Methods. 2000 Nov 15;103(1):23-37. doi: 10.1016/s0165-0270(00)00293-4. J Neurosci Methods. 2000. PMID: 11074093 Review.
108 results